Can MRI better spot early breast cancer spread?
NCT ID NCT00874458
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether MRI can more accurately measure the size of ductal carcinoma in situ (a very early form of breast cancer) compared to standard mammography. Forty women with the condition had MRI scans before surgery. Researchers then compared the MRI results with the actual tumor size found during surgery to see how well MRI predicts the extent of disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- magnetic resonance imaging (MRI)
- What this could lead to
- If successful, MRI could become a standard tool to more accurately assess how far ductal carcinoma in situ has spread before surgery.
- What could go wrong
- This is a small, completed study with only 40 participants, so results may not apply to all patients. MRI may not always match surgical findings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?